nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Progesterone—uterine cancer	0.159	0.296	CbGbCtD
Ranolazine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.153	0.284	CbGbCtD
Ranolazine—CYP3A4—Progesterone—uterine cancer	0.101	0.188	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—uterine cancer	0.0487	0.0903	CbGbCtD
Ranolazine—CYP3A4—Etoposide—uterine cancer	0.0454	0.0842	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—uterine cancer	0.031	0.0574	CbGbCtD
Ranolazine—Carvedilol—VEGFA—uterine cancer	0.00151	1	CrCbGaD
Ranolazine—Dyspepsia—Progesterone—uterine cancer	0.00148	0.00323	CcSEcCtD
Ranolazine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00323	CcSEcCtD
Ranolazine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00321	CcSEcCtD
Ranolazine—Decreased appetite—Progesterone—uterine cancer	0.00147	0.00319	CcSEcCtD
Ranolazine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00317	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00146	0.00317	CcSEcCtD
Ranolazine—Fatigue—Progesterone—uterine cancer	0.00145	0.00316	CcSEcCtD
Ranolazine—Constipation—Progesterone—uterine cancer	0.00144	0.00314	CcSEcCtD
Ranolazine—Pancytopenia—Etoposide—uterine cancer	0.00144	0.00313	CcSEcCtD
Ranolazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00311	CcSEcCtD
Ranolazine—Creatinine increased—Epirubicin—uterine cancer	0.00142	0.0031	CcSEcCtD
Ranolazine—Feeling abnormal—Progesterone—uterine cancer	0.00139	0.00302	CcSEcCtD
Ranolazine—Gait disturbance—Epirubicin—uterine cancer	0.00139	0.00302	CcSEcCtD
Ranolazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00301	CcSEcCtD
Ranolazine—Coordination abnormal—Epirubicin—uterine cancer	0.00138	0.003	CcSEcCtD
Ranolazine—Gastrointestinal pain—Progesterone—uterine cancer	0.00138	0.003	CcSEcCtD
Ranolazine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00299	CcSEcCtD
Ranolazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00296	CcSEcCtD
Ranolazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00296	CcSEcCtD
Ranolazine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00293	CcSEcCtD
Ranolazine—Urticaria—Progesterone—uterine cancer	0.00134	0.00291	CcSEcCtD
Ranolazine—Abdominal pain—Progesterone—uterine cancer	0.00133	0.0029	CcSEcCtD
Ranolazine—Renal failure—Etoposide—uterine cancer	0.00133	0.00289	CcSEcCtD
Ranolazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00289	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00287	CcSEcCtD
Ranolazine—Creatinine increased—Doxorubicin—uterine cancer	0.00132	0.00287	CcSEcCtD
Ranolazine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00287	CcSEcCtD
Ranolazine—Leukopenia—Dactinomycin—uterine cancer	0.00131	0.00284	CcSEcCtD
Ranolazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00284	CcSEcCtD
Ranolazine—Gait disturbance—Doxorubicin—uterine cancer	0.00128	0.0028	CcSEcCtD
Ranolazine—Blood urea increased—Epirubicin—uterine cancer	0.00128	0.00278	CcSEcCtD
Ranolazine—Coordination abnormal—Doxorubicin—uterine cancer	0.00128	0.00278	CcSEcCtD
Ranolazine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00274	CcSEcCtD
Ranolazine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00272	CcSEcCtD
Ranolazine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00264	CcSEcCtD
Ranolazine—Asthenia—Progesterone—uterine cancer	0.00121	0.00263	CcSEcCtD
Ranolazine—Hypoaesthesia—Etoposide—uterine cancer	0.00121	0.00263	CcSEcCtD
Ranolazine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00263	CcSEcCtD
Ranolazine—Urinary tract disorder—Etoposide—uterine cancer	0.0012	0.00261	CcSEcCtD
Ranolazine—Pruritus—Progesterone—uterine cancer	0.00119	0.0026	CcSEcCtD
Ranolazine—Urethral disorder—Etoposide—uterine cancer	0.00119	0.00259	CcSEcCtD
Ranolazine—Blood urea increased—Doxorubicin—uterine cancer	0.00118	0.00258	CcSEcCtD
Ranolazine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00117	0.00254	CcSEcCtD
Ranolazine—Anorexia—Dactinomycin—uterine cancer	0.00114	0.00247	CcSEcCtD
Ranolazine—Eye disorder—Etoposide—uterine cancer	0.00113	0.00247	CcSEcCtD
Ranolazine—Cardiac disorder—Etoposide—uterine cancer	0.00113	0.00245	CcSEcCtD
Ranolazine—Dizziness—Progesterone—uterine cancer	0.00112	0.00243	CcSEcCtD
Ranolazine—Angiopathy—Etoposide—uterine cancer	0.0011	0.0024	CcSEcCtD
Ranolazine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00239	CcSEcCtD
Ranolazine—Mediastinal disorder—Etoposide—uterine cancer	0.00109	0.00238	CcSEcCtD
Ranolazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00235	CcSEcCtD
Ranolazine—Vomiting—Progesterone—uterine cancer	0.00107	0.00233	CcSEcCtD
Ranolazine—Renal failure acute—Epirubicin—uterine cancer	0.00107	0.00232	CcSEcCtD
Ranolazine—Rash—Progesterone—uterine cancer	0.00106	0.00231	CcSEcCtD
Ranolazine—Dermatitis—Progesterone—uterine cancer	0.00106	0.00231	CcSEcCtD
Ranolazine—Headache—Progesterone—uterine cancer	0.00106	0.0023	CcSEcCtD
Ranolazine—Hot flush—Epirubicin—uterine cancer	0.00105	0.00229	CcSEcCtD
Ranolazine—Menopausal symptoms—Epirubicin—uterine cancer	0.00104	0.00227	CcSEcCtD
Ranolazine—Decreased appetite—Dactinomycin—uterine cancer	0.00104	0.00225	CcSEcCtD
Ranolazine—Fatigue—Dactinomycin—uterine cancer	0.00103	0.00224	CcSEcCtD
Ranolazine—Muscle spasms—Etoposide—uterine cancer	0.00102	0.00221	CcSEcCtD
Ranolazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.0022	CcSEcCtD
Ranolazine—Lethargy—Epirubicin—uterine cancer	0.001	0.00218	CcSEcCtD
Ranolazine—Nausea—Progesterone—uterine cancer	0.001	0.00218	CcSEcCtD
Ranolazine—Renal failure acute—Doxorubicin—uterine cancer	0.000986	0.00215	CcSEcCtD
Ranolazine—Pain in extremity—Epirubicin—uterine cancer	0.000984	0.00214	CcSEcCtD
Ranolazine—Diplopia—Epirubicin—uterine cancer	0.000984	0.00214	CcSEcCtD
Ranolazine—Feeling abnormal—Dactinomycin—uterine cancer	0.000982	0.00214	CcSEcCtD
Ranolazine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000975	0.00212	CcSEcCtD
Ranolazine—Hot flush—Doxorubicin—uterine cancer	0.000973	0.00212	CcSEcCtD
Ranolazine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000972	0.00211	CcSEcCtD
Ranolazine—Menopausal symptoms—Doxorubicin—uterine cancer	0.000965	0.0021	CcSEcCtD
Ranolazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000963	0.0021	CcSEcCtD
Ranolazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000963	0.00209	CcSEcCtD
Ranolazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000957	0.00208	CcSEcCtD
Ranolazine—Vertigo—Etoposide—uterine cancer	0.00095	0.00207	CcSEcCtD
Ranolazine—Leukopenia—Etoposide—uterine cancer	0.000946	0.00206	CcSEcCtD
Ranolazine—Abdominal pain—Dactinomycin—uterine cancer	0.000942	0.00205	CcSEcCtD
Ranolazine—Loss of consciousness—Etoposide—uterine cancer	0.000929	0.00202	CcSEcCtD
Ranolazine—Lethargy—Doxorubicin—uterine cancer	0.000929	0.00202	CcSEcCtD
Ranolazine—Cough—Etoposide—uterine cancer	0.000922	0.00201	CcSEcCtD
Ranolazine—Blood creatinine increased—Epirubicin—uterine cancer	0.000922	0.00201	CcSEcCtD
Ranolazine—Dehydration—Epirubicin—uterine cancer	0.000915	0.00199	CcSEcCtD
Ranolazine—Pain in extremity—Doxorubicin—uterine cancer	0.00091	0.00198	CcSEcCtD
Ranolazine—Diplopia—Doxorubicin—uterine cancer	0.00091	0.00198	CcSEcCtD
Ranolazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000908	0.00197	CcSEcCtD
Ranolazine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000899	0.00195	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000894	0.00194	CcSEcCtD
Ranolazine—Breast disorder—Epirubicin—uterine cancer	0.000889	0.00193	CcSEcCtD
Ranolazine—Confusional state—Etoposide—uterine cancer	0.00087	0.00189	CcSEcCtD
Ranolazine—Asthenia—Dactinomycin—uterine cancer	0.000855	0.00186	CcSEcCtD
Ranolazine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000853	0.00186	CcSEcCtD
Ranolazine—Dehydration—Doxorubicin—uterine cancer	0.000847	0.00184	CcSEcCtD
Ranolazine—Thrombocytopenia—Etoposide—uterine cancer	0.000845	0.00184	CcSEcCtD
Ranolazine—Eosinophilia—Epirubicin—uterine cancer	0.000842	0.00183	CcSEcCtD
Ranolazine—Skin disorder—Etoposide—uterine cancer	0.000838	0.00182	CcSEcCtD
Ranolazine—Hyperhidrosis—Etoposide—uterine cancer	0.000834	0.00181	CcSEcCtD
Ranolazine—Pancreatitis—Epirubicin—uterine cancer	0.000834	0.00181	CcSEcCtD
Ranolazine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000831	0.00181	CcSEcCtD
Ranolazine—Breast disorder—Doxorubicin—uterine cancer	0.000823	0.00179	CcSEcCtD
Ranolazine—Anorexia—Etoposide—uterine cancer	0.000822	0.00179	CcSEcCtD
Ranolazine—Pancytopenia—Epirubicin—uterine cancer	0.000807	0.00176	CcSEcCtD
Ranolazine—Hypotension—Etoposide—uterine cancer	0.000806	0.00175	CcSEcCtD
Ranolazine—Dysuria—Epirubicin—uterine cancer	0.000795	0.00173	CcSEcCtD
Ranolazine—Eosinophilia—Doxorubicin—uterine cancer	0.000779	0.00169	CcSEcCtD
Ranolazine—Paraesthesia—Etoposide—uterine cancer	0.000775	0.00169	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—uterine cancer	0.000771	0.00168	CcSEcCtD
Ranolazine—Weight decreased—Epirubicin—uterine cancer	0.000769	0.00167	CcSEcCtD
Ranolazine—Dyspnoea—Etoposide—uterine cancer	0.000769	0.00167	CcSEcCtD
Ranolazine—Somnolence—Etoposide—uterine cancer	0.000767	0.00167	CcSEcCtD
Ranolazine—Vomiting—Dactinomycin—uterine cancer	0.000758	0.00165	CcSEcCtD
Ranolazine—Rash—Dactinomycin—uterine cancer	0.000751	0.00163	CcSEcCtD
Ranolazine—Decreased appetite—Etoposide—uterine cancer	0.00075	0.00163	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—uterine cancer	0.000747	0.00163	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—uterine cancer	0.000745	0.00162	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000745	0.00162	CcSEcCtD
Ranolazine—Fatigue—Etoposide—uterine cancer	0.000744	0.00162	CcSEcCtD
Ranolazine—Constipation—Etoposide—uterine cancer	0.000738	0.0016	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—uterine cancer	0.000736	0.0016	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—uterine cancer	0.000723	0.00157	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—uterine cancer	0.000715	0.00156	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—uterine cancer	0.000712	0.00155	CcSEcCtD
Ranolazine—Feeling abnormal—Etoposide—uterine cancer	0.000711	0.00155	CcSEcCtD
Ranolazine—Nausea—Dactinomycin—uterine cancer	0.000708	0.00154	CcSEcCtD
Ranolazine—Gastrointestinal pain—Etoposide—uterine cancer	0.000705	0.00153	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—uterine cancer	0.000693	0.00151	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—uterine cancer	0.00069	0.0015	CcSEcCtD
Ranolazine—Urticaria—Etoposide—uterine cancer	0.000685	0.00149	CcSEcCtD
Ranolazine—Abdominal pain—Etoposide—uterine cancer	0.000682	0.00148	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—uterine cancer	0.000677	0.00147	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—uterine cancer	0.000672	0.00146	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—uterine cancer	0.00067	0.00146	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—uterine cancer	0.000669	0.00146	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—uterine cancer	0.000669	0.00146	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—uterine cancer	0.000667	0.00145	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—uterine cancer	0.000662	0.00144	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—uterine cancer	0.000656	0.00143	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—uterine cancer	0.000641	0.00139	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—uterine cancer	0.000636	0.00138	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—uterine cancer	0.000635	0.00138	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—uterine cancer	0.000632	0.00137	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000627	0.00136	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000622	0.00135	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—uterine cancer	0.00062	0.00135	CcSEcCtD
Ranolazine—Asthenia—Etoposide—uterine cancer	0.000619	0.00135	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000619	0.00135	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—uterine cancer	0.000617	0.00134	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—uterine cancer	0.000617	0.00134	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—uterine cancer	0.000613	0.00133	CcSEcCtD
Ranolazine—Pruritus—Etoposide—uterine cancer	0.00061	0.00133	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—uterine cancer	0.000608	0.00132	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—uterine cancer	0.000607	0.00132	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—uterine cancer	0.000596	0.0013	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—uterine cancer	0.000592	0.00129	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—uterine cancer	0.000588	0.00128	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—uterine cancer	0.000587	0.00128	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—uterine cancer	0.000584	0.00127	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—uterine cancer	0.000584	0.00127	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—uterine cancer	0.000571	0.00124	CcSEcCtD
Ranolazine—Dizziness—Etoposide—uterine cancer	0.00057	0.00124	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—uterine cancer	0.00057	0.00124	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000568	0.00123	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—uterine cancer	0.000563	0.00122	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—uterine cancer	0.000558	0.00121	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—uterine cancer	0.000552	0.0012	CcSEcCtD
Ranolazine—Vomiting—Etoposide—uterine cancer	0.000548	0.00119	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—uterine cancer	0.000548	0.00119	CcSEcCtD
Ranolazine—Rash—Etoposide—uterine cancer	0.000544	0.00118	CcSEcCtD
Ranolazine—Dermatitis—Etoposide—uterine cancer	0.000543	0.00118	CcSEcCtD
Ranolazine—Headache—Etoposide—uterine cancer	0.00054	0.00118	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—uterine cancer	0.00054	0.00118	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—uterine cancer	0.000532	0.00116	CcSEcCtD
Ranolazine—Syncope—Epirubicin—uterine cancer	0.000531	0.00116	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—uterine cancer	0.00053	0.00115	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—uterine cancer	0.000527	0.00115	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—uterine cancer	0.000524	0.00114	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—uterine cancer	0.000521	0.00113	CcSEcCtD
Ranolazine—Cough—Epirubicin—uterine cancer	0.000517	0.00112	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—uterine cancer	0.000517	0.00112	CcSEcCtD
Ranolazine—Nausea—Etoposide—uterine cancer	0.000512	0.00111	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—uterine cancer	0.000503	0.00109	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000501	0.00109	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—uterine cancer	0.000493	0.00107	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—uterine cancer	0.000493	0.00107	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—uterine cancer	0.000492	0.00107	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—uterine cancer	0.000491	0.00107	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—uterine cancer	0.000488	0.00106	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—uterine cancer	0.000484	0.00105	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—uterine cancer	0.000482	0.00105	CcSEcCtD
Ranolazine—Cough—Doxorubicin—uterine cancer	0.000478	0.00104	CcSEcCtD
Ranolazine—Shock—Epirubicin—uterine cancer	0.000476	0.00103	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—uterine cancer	0.000474	0.00103	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—uterine cancer	0.000473	0.00103	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—uterine cancer	0.00047	0.00102	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—uterine cancer	0.000467	0.00102	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—uterine cancer	0.000465	0.00101	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000463	0.00101	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—uterine cancer	0.000461	0.001	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—uterine cancer	0.000456	0.000993	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—uterine cancer	0.000452	0.000983	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—uterine cancer	0.000451	0.000981	CcSEcCtD
Ranolazine—Shock—Doxorubicin—uterine cancer	0.00044	0.000958	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—uterine cancer	0.000439	0.000955	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000438	0.000953	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—uterine cancer	0.000437	0.000951	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—uterine cancer	0.000435	0.000945	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—uterine cancer	0.000434	0.000945	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000433	0.000941	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—uterine cancer	0.000431	0.000938	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—uterine cancer	0.00043	0.000935	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—uterine cancer	0.000426	0.000928	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—uterine cancer	0.000426	0.000926	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—uterine cancer	0.00042	0.000914	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—uterine cancer	0.000418	0.00091	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000417	0.000908	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—uterine cancer	0.000417	0.000907	CcSEcCtD
Ranolazine—Constipation—Epirubicin—uterine cancer	0.000413	0.0009	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—uterine cancer	0.000405	0.00088	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—uterine cancer	0.000402	0.000874	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—uterine cancer	0.000399	0.000868	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—uterine cancer	0.000398	0.000867	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—uterine cancer	0.000398	0.000865	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000395	0.00086	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—uterine cancer	0.000394	0.000857	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—uterine cancer	0.000389	0.000846	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000386	0.00084	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—uterine cancer	0.000386	0.000839	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—uterine cancer	0.000384	0.000836	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—uterine cancer	0.000383	0.000832	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—uterine cancer	0.000382	0.000832	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—uterine cancer	0.000369	0.000802	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000366	0.000796	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—uterine cancer	0.000355	0.000773	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—uterine cancer	0.000354	0.000769	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—uterine cancer	0.000347	0.000755	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—uterine cancer	0.000342	0.000744	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—uterine cancer	0.000321	0.000698	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—uterine cancer	0.00032	0.000696	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—uterine cancer	0.000317	0.000689	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—uterine cancer	0.000307	0.000669	CcSEcCtD
Ranolazine—Rash—Epirubicin—uterine cancer	0.000305	0.000663	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—uterine cancer	0.000305	0.000663	CcSEcCtD
Ranolazine—Headache—Epirubicin—uterine cancer	0.000303	0.000659	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—uterine cancer	0.000296	0.000644	CcSEcCtD
Ranolazine—Nausea—Epirubicin—uterine cancer	0.000287	0.000625	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—uterine cancer	0.000284	0.000619	CcSEcCtD
Ranolazine—Rash—Doxorubicin—uterine cancer	0.000282	0.000614	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—uterine cancer	0.000282	0.000613	CcSEcCtD
Ranolazine—Headache—Doxorubicin—uterine cancer	0.00028	0.00061	CcSEcCtD
Ranolazine—Nausea—Doxorubicin—uterine cancer	0.000266	0.000578	CcSEcCtD
